United Therapeutics (UTHR) Minority Interest (2009 - 2016)

United Therapeutics has disclosed Minority Interest across 8 years of filings, most recently posting $10.9 million for Q4 2016.

• In Q4 2016, Minority Interest changed 0.0% year-over-year to $10.9 million; the TTM figure through Dec 2016 stood at $10.9 million (changed 0.0% YoY), while the FY2016 annual figure was $10.9 million, changed 0.0% from the prior year.
• Minority Interest came in at $10.9 million for Q4 2016 at United Therapeutics, roughly flat from $10.9 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $10.9 million in Q4 2015 to a low of $10.9 million in Q1 2012.
• Average Minority Interest over 5 years is $10.9 million, with a median of $10.9 million recorded in 2012.
• Year-over-year, Minority Interest changed 0.0% in 2012 and rose 0.17% in 2015.
• Over 5 years, Minority Interest stood at $10.9 million in 2012, then changed by 0.0% to $10.9 million in 2013, then changed by 0.0% to $10.9 million in 2014, then increased by 0.17% to $10.9 million in 2015, then changed by 0.0% to $10.9 million in 2016.
• Per Business Quant data, the three most recent Minority Interest figures were $10.9 million in Q4 2016, $10.9 million in Q4 2015, and $10.9 million in Q3 2015.